We also tried to understand the relationship between MALAT1, β-catenin and Ezh2 in ESCC, and seek the cellular and molecular mechanisms of the occurrence and progression of ESCC and find a potential therapeutic target for ESCC. This evidence concerns the gene MALAT1 and esophageal squamous cell carcinoma.